Basilea Pharmaceutica Ltd, Allschwil header image

Basilea Pharmaceutica Ltd, Allschwil

BSLN

Equity

ISIN CH0011432447 / Valor 1143244

SIX Swiss Exchange (2026-05-04)

CHF 54.90+2.06%

Basilea Pharmaceutica Ltd, Allschwil
UMushroom community rating:

3.18 3 votes No rating yet

NegativeNeutralPositive

About company

Basilea Pharmaceutica Ltd, based in Allschwil, Switzerland, is a commercial-stage biopharmaceutical company listed on the SIX Swiss Exchange under the ticker BSLN. The company specializes in the research, development, and commercialization of innovative pharmaceutical products, primarily focusing on anti-infective therapies. Basilea aims to address significant medical challenges by developing treatments for serious and life-threatening conditions. Its strategic focus on anti-infectives positions it to tackle pressing global health issues, such as antibiotic resistance and the need for effective antifungal treatments. Through its commitment to advancing medical science, Basilea seeks to provide solutions that improve patient outcomes in critical care settings.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

23.1%1Y

25.9%3Y

20.1%5Y

Performance

30.2%1Y

29.5%3Y

31.1%5Y

Volatility

857 M

Market cap (USD)

27,665

Daily traded volume (Shares)

42.05 / 40.85

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.18

3 votes

Performance:

3.09

Innovation:

3.55

Society:

3.55

Nature:

3.55

Filippo Scacchi

Switzerland, 22 Mar 2026

Watch out

Camilla Mossetti

Switzerland, 21 Mar 2026

Good performance lately

N K

Switzerland, 26 Mar 2025

.

EQUITIES OF THE SAME SECTOR

Embla Medical hf

Embla Medical hf Valor: 1060135

Annual Return

-50%0%+50%

Risk level

110

1.71%DKK 26.75

H. Lundbeck A/S

H. Lundbeck A/S Valor: 119252584

Annual Return

-50%0%+50%

Risk level

110

-1.13%DKK 35.00

Teladoc Health Inc

Teladoc Health Inc Valor: 28438140

Annual Return

-50%0%+50%

Risk level

110

6.60%USD 6.46

Bristol-Myers Squibb Co

Bristol-Myers Squibb Co Valor: 914188

Annual Return

-50%0%+50%

Risk level

110

-3.91%USD 58.22

DocMorris Ltd

DocMorris Ltd Valor: 4261528

Annual Return

-50%0%+50%

Risk level

110

-1.11%CHF 7.15

Demant A/S

Demant A/S Valor: 32651962

Annual Return

-50%0%+50%

Risk level

110

3.47%DKK 209.00

Ensign Group Inc

Ensign Group Inc Valor: 3109721

Annual Return

-50%0%+50%

Risk level

110

-1.59%USD 183.72

Estee Lauder Companies Inc

Estee Lauder Companies Inc Valor: 99350

Annual Return

-50%0%+50%

Risk level

110

3.38%USD 79.30

Alk-Abello A/S

Alk-Abello A/S Valor: 117689788

Annual Return

-50%0%+50%

Risk level

110

1.51%DKK 242.00

Merck & Co Inc

Merck & Co Inc Valor: 10683053

Annual Return

-50%0%+50%

Risk level

110

2.73%USD 112.16

SIX

FactSet

Clearbit

Logos provided by Clearbit